• Medicine
  • Published in Cutis 2016

An update on neurotoxin products and administration methods.

@article{Lanoue2016AnUO,
  title={An update on neurotoxin products and administration methods.},
  author={Julien Lanoue and Joanna Dong and Timothy D. Bundy Do and Gary Goldenberg},
  journal={Cutis},
  year={2016},
  volume={98 3},
  pages={
          163;166;197
        }
}
Since onabotulinumtoxinA for nonsurgical aesthetic enhancement of glabellar lines was initially reported, the popularity of botulinum neurotoxin (BoNT) products among both clinicians and consumers has rapidly grown, and we have seen several additional BoNT formulations enter the market. As the demand for minimally invasive cosmetic procedures continues to increase, we will see the introduction of additional formulations of BoNT products as well as new delivery devices and administration… CONTINUE READING
4
Twitter Mentions

Topics from this paper.

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES

Consensus statement regarding storage and reuse of previously reconstituted neuromodulators.

Injecting botulinum toxin at different depths is not effective for the correction of eyebrow asymmetry.

Optimal dosage of botulinum toxin type A for treatment of glabellar frown lines: efficacy and safety in a clinical trial.

  • Zheng Feng, Qiuning Sun, +6 authors Hengjin Li
  • Medicine
  • Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2015

Safety and efficacy of RT002, an injectable botulinum toxin type A, for treating glabellar lines: results of a phase 1/2, open-label, sequential dose-escalation study

  • E Garcia-Murray, ML Velasco Villasenor, B Acevedo
  • Dermatol Surg. 2015;41(suppl 1):S47-S55
  • 2015